UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 126

Sortiert nach

Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer

The New England journal of medicine, 2019-07, Vol.381 (4), p.307-316

2019

Link zum Volltext

Verfügbarkeit prüfen

Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study

PLoS medicine, 2016-12, Vol.13 (12), p.e1002198-e1002198

2016

Link zum Volltext

Verfügbarkeit prüfen

Demon Entrepreneurs: Refashioning the 'Greek Genius' in Modern Times

1, 2023

Link zum Volltext

Verfügbarkeit prüfen

Molecular pathogenesis of ovarian clear cell carcinoma

Future oncology (London, England), 2015-05, Vol.11 (9), p.1389-1405

2015

Link zum Volltext

Verfügbarkeit prüfen

Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3 trial

The lancet oncology, 2014-02, Vol.15 (2), p.201-212

2014

Link zum Volltext

Verfügbarkeit prüfen

Ribociclib, a CDK 4/6 inhibitor, plus endocrine therapy in Asian women with advanced breast cancer

Cancer science, 2020-09, Vol.111 (9), p.3313-3326

2020

Link zum Volltext

Verfügbarkeit prüfen

Docetaxel and its potential in the treatment of refractory esophagogastric adenocarcinoma

Therapeutic Advances in Gastroenterology, 2015-07, Vol.8 (4), p.189-205

2015

Link zum Volltext

Verfügbarkeit prüfen

Relationship among DDR gene mutations, TMB and PD-L1 in solid tumour genomes identified using clinically actionable biomarker assays

NPJ precision oncology, 2023-10, Vol.7 (1), p.103-103, Article 103

2023

Link zum Volltext

Verfügbarkeit prüfen

Comment on the FOWARC Study Report

Journal of clinical oncology, 2017-05, Vol.35 (13), p.1494-1494

Gounaris, Ioannis

2017

Link zum Volltext

Verfügbarkeit prüfen

Ovarian clear cell carcinoma-bad endometriosis or bad endometrium?

The Journal of pathology, 2011-10, Vol.225 (2), p.157-160

2011

Link zum Volltext

Verfügbarkeit prüfen

The Macedonian Front, 1915-1918: Politics, Society and Culture in Time of War

1st, 2022

Link zum Volltext

Verfügbarkeit prüfen

Pulmomary embolism in Bradford, UK: role of end-tidal CO^sub 2^ as a screening tool

Clinical medicine (London, England), 2014-08, Vol.14 (4), p.455

Gounaris, Ioannis

2014

Link zum Volltext

Verfügbarkeit prüfen

Pulmomary embolism in Bradford, UK: role of end-tidal CO2 as a screening tool

Clinical medicine (London, England), 2014-08, Vol.14 (4), p.455-455

Gounaris, Ioannis

2014

Link zum Volltext

Verfügbarkeit prüfen

Practical implementation of the partial ordering continual reassessment method in a Phase I combination‐schedule dose‐finding trial

Statistics in medicine, 2022-12, Vol.41 (30), p.5789-5809

2022

Link zum Volltext

Verfügbarkeit prüfen

Survival of patients with metastatic breast cancer with or without locoregional therapy

The lancet oncology, 2015-12, Vol.16 (16), p.e585-e585

Gounaris, Ioannis

2015

Link zum Volltext

Verfügbarkeit prüfen

First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors

Clinical cancer research, 2024-05, Vol.30 (10), p.2057

2024

Link zum Volltext

Verfügbarkeit prüfen

A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumours

British journal of cancer, 2024-04, Vol.130 (7), p.1131-1140

2024

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2312: Single-cell low pass whole genome sequencing for copy-number profiling in circulating tumor cells from prostate, non-small cell lung and breast cancers

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.2312-2312

2023

Link zum Volltext

Verfügbarkeit prüfen

A first-in-human phase I study of ATR inhibitor M1774 in patients with solid tumors

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.TPS3153-TPS3153

2021

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant trials in early breast cancer: pathological response at surgery and correlation to longer term outcomes - what does it all mean?

BMC medicine, 2015-09, Vol.13 (1), p.234-234, Article 234

2015

Link zum Volltext

Verfügbarkeit prüfen

Five-gene signature in non-small-cell lung cancer

The New England journal of medicine, 2007-04, Vol.356 (15), p.1582; author reply 1583

Gounaris, Ioannis

2007

Link zum Volltext

Verfügbarkeit prüfen

Survival of patients with metastatic breast cancer with or without locoregional therapy

The lancet oncology, 2015-12, Vol.16 (16), p.e585-e586

Fouad, Tamer M

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 126

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(121)

Publikationsform

Sprache

Englisch
(126)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(56)
Life Sciences & Biomedicine
(45)
Humans
(37)
Female
(28)
Oncology
(21)
Adult
(15)
Middle Aged
(15)
Aged
(14)
Breast Cancer
(11)
Technology
(11)
Chemotherapy
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(9)
Computer Science
(9)
General & Internal Medicine
(9)
Medicine, General & Internal
(9)
Metastasis
(9)
Breast Neoplasms - Drug Therapy
(7)
Gene Expression
(7)
Ovarian Cancer
(7)
Cancer Therapies
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer

Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study

Demon Entrepreneurs: Refashioning the 'Greek Genius' in Modern Times

Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial

Molecular pathogenesis of ovarian clear cell carcinoma

Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3 trial

Ribociclib, a CDK 4/6 inhibitor, plus endocrine therapy in Asian women with advanced breast cancer

Docetaxel and its potential in the treatment of refractory esophagogastric adenocarcinoma

Relationship among DDR gene mutations, TMB and PD-L1 in solid tumour genomes identified using clinically actionable biomarker assays

Comment on the FOWARC Study Report

Ovarian clear cell carcinoma-bad endometriosis or bad endometrium?

The Macedonian Front, 1915-1918: Politics, Society and Culture in Time of War

Pulmomary embolism in Bradford, UK: role of end-tidal CO^sub 2^ as a screening tool

Pulmomary embolism in Bradford, UK: role of end-tidal CO2 as a screening tool

Practical implementation of the partial ordering continual reassessment method in a Phase I combination‐schedule dose‐finding trial

Survival of patients with metastatic breast cancer with or without locoregional therapy

Enhanced detection of circulating tumor DNA by fragment size analysis

First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors

A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumours

Abstract 2312: Single-cell low pass whole genome sequencing for copy-number profiling in circulating tumor cells from prostate, non-small cell lung and breast cancers

A first-in-human phase I study of ATR inhibitor M1774 in patients with solid tumors

Neoadjuvant trials in early breast cancer: pathological response at surgery and correlation to longer term outcomes - what does it all mean?

Five-gene signature in non-small-cell lung cancer

Survival of patients with metastatic breast cancer with or without locoregional therapy

Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2x2 factorial randomised phase 3 trial

Suchergebnisse filtern